Critical IPC skipped during scale-up – regulatory impact assessment case study


Published on 05/01/2026

Further reading: Manufacturing Deviation Case Studies

Assessing the Regulatory Impact of Skipped Critical IPCs During Scale-Up

In pharmaceutical manufacturing, ensuring the integrity of every process step is vital. A recent case study highlights a significant deviation that occurred during the scale-up of a biopharmaceutical product. A critical in-process control (IPC) was unintentionally skipped, prompting immediate regulatory concerns and a deep investigation into the incident. This article walks through the steps involved in detecing, containing, investigating, and addressing this critical deviation, ultimately providing actionable insights that can help professionals avoid similar pitfalls.

If you want a complete overview with practical prevention steps, see this Manufacturing Deviation Case Studies.

After reading this article, pharma professionals will be equipped to identify symptoms of potential deviations in their manufacturing processes, contain deviations effectively, and implement robust CAPA strategies to prevent recurrence.

Symptoms/Signals on the Floor or in the Lab

Early detection of deviations is crucial in mitigating their impact. In this particular case, several signals indicated potential issues:

  • Batch Variability: Increased variability in product characteristics was observed in several
batches.
  • Product Quality Issues: Initial analytical results demonstrated deviations in assay and purity specifications from established limits.
  • Employee Reports: Operators noted discrepancies in the execution of the IPC checks during the scale-up process.
  • These symptoms compelled the Quality Assurance (QA) team to initiate an immediate assessment. Such signals must not be ignored, as they can lead to significant regulatory repercussions if not addressed promptly.

    Likely Causes

    Determining the cause of skipped critical IPCs requires an analysis of potential failure modes across several categories. Here are some likely causes identified in this scenario:

    Cause Category Details
    Materials Use of unqualified materials that led to altered process parameters.
    Method Lack of clarity in the procedural documentation related to IPC checks.
    Machine Improperly calibrated equipment causing confusion in IPC timing.
    Man Insufficient training of personnel involved in the scale-up process.
    Measurement Faulty data recording leading to misinformation regarding IPC execution.
    Environment Suboptimal working conditions causing distractions and oversight.

    Immediate Containment Actions (first 60 minutes)

    Upon confirmation of the skipped IPC, the immediate goal was to contain the potential fallout:

    • Stop the Process: The scale-up production was halted to prevent further deviations.
    • Notify Stakeholders: Key stakeholders, including QA, operations, and regulatory affairs, were informed of the incident.
    • Quarantine Affected Batches: All batches produced during the affected time frame were quarantined and labeled appropriately.
    • Assessment of Risk: An initial risk assessment was conducted to evaluate the impact on product quality and patient safety.

    These actions ensured that the situation was controlled swiftly while the underlying causes could be investigated further.

    Investigation Workflow

    The investigation process involved a systematic approach to collect relevant data and evidence:

    1. Document Review: Procedures related to IPC, batch records, and operator training logs were reviewed.
    2. Interviews: Key personnel involved in the scale-up and IPC execution were interviewed to gather insights.
    3. Data Collection: Collect and analyze any available process data that could indicate the timing of the IPC execution.
    4. Root Cause Analysis Initiation: Prepare for root cause analysis tools based on the data collected.

    Special attention was given to evidence of process adherence compared to established SOPs and any deviations therein. The collected data laid the groundwork for identifying the root causes.

    Root Cause Tools and When to Use Which

    Root cause analysis is essential for understanding how the IPC could have been skipped. Several tools can be employed:

    • 5-Why Analysis: Used to drill down into the ‘why’ of the skipped IPC. It involves asking five consecutive why questions until the root cause is revealed.
    • Fishbone Diagram: Helpful in categorizing the various causes identified in the investigation, allowing teams to visualize potential areas of failure clearly.
    • Fault Tree Analysis: A systematic, deductive approach used to determine various paths that could lead to the deviation, useful for complex situations.

    In this scenario, the team began with the 5-Why analysis to quickly identify underlying issues like training and procedural gaps. As the investigation developed, a combination of tools was employed to comprehensively understand the situation.

    CAPA Strategy

    Implementing a corrective and preventive action (CAPA) strategy is key in addressing the root causes identified. The strategy consisted of three steps:

    • Correction: Immediate training sessions were organized for operators to reinforce the importance of conducting IPC checks diligently.
    • Corrective Actions: The standard operating procedures (SOPs) were revised to clarify IPC requirements, and additional checks were introduced to ensure compliance in the future.
    • Preventive Actions: Continuous monitoring measures were established, including routine audits and enhanced training protocols for new hires.

    These CAPA actions were documented comprehensively, ensuring that evidence of implementation would be readily available for future inspections.

    Control Strategy & Monitoring

    A robust control strategy and monitoring system were developed to preempt similar issues in the future:

    • Statistical Process Control (SPC): Introduced to monitor critical process parameters, including those related to IPC execution.
    • Sampling Plans: Enhanced sampling plans were established to audit IPC checkpoints regularly.
    • Alarms and Notifications: Implemented automated alerts for any deviations during the IPC checks to ensure immediate corrective action.
    • Verification Steps: Added steps in the batch production record review to verify that all IPCs were conducted as per the updated SOPs.

    Continuous assessment ensures that any deviations are caught early, and actions can be taken swiftly.

    Related Reads

    Validation / Re-qualification / Change Control Impact

    Given the nature of the deviation, the manufacturer needed to conduct validation and potential re-qualification activities:

    • Validation: The updated processes and procedures needed validation to confirm their effectiveness in preventing future deviations.
    • Re-qualification of Equipment: Any equipment involved in the failed IPC process was subjected to re-qualification to ensure it operated within specifications.
    • Change Control: Any changes made to processes or procedures resulted in a change control record, ensuring all modifications were captured and approved.

    This structured approach ensured that the outcome of the deviations was properly managed and documented for regulatory compliance.

    Inspection Readiness: What Evidence to Show

    During regulatory inspections, it is essential to present comprehensive evidence demonstrating that proper handling of the deviation was accomplished:

    • Corrective Action Records: Documented CAPA actions and their status, including training logs.
    • Batch Records: Detailed batch records illustrating the execution of IPCs before and after the incident.
    • Investigation Reports: Final investigation report summarizing findings, root causes, and corrective/preventive actions taken.
    • Change Control Documentation: Records reflecting the changes made to processes based on the findings of the investigation.

    These documents should be organized and easily accessible during inspections to assure compliance with regulatory standards.

    FAQs

    What should I do if an IPC is skipped during production?

    Immediately halt production, quarantine affected batches, and notify relevant stakeholders to initiate a root cause investigation.

    How can I ensure regulatory compliance after a deviation?

    Implement a thorough CAPA strategy, conduct necessary training, and ensure all documentation is up-to-date and stored for inspection readiness.

    What tools are best for root cause analysis?

    Popular tools include 5-Why analysis, Fishbone diagrams, and Fault Tree analysis, depending on the complexity of the issue.

    How do I maintain ongoing compliance with IPCs?

    Establish robust monitoring and SPC measures to continuously oversee IPC execution throughout production cycles.

    Is continuous training necessary in our facility?

    Yes, continuous training is essential for maintaining competence among personnel and ensuring compliance with SOPs and regulations.

    What is the effect of skipping an IPC?

    Skipping an IPC can lead to quality issues, regulatory penalties, and potential risks to patient safety, making it critical to manage deviations effectively.

    How can I document a deviation and CAPA responses?

    Document all corrective actions, individuals involved, investigation findings, and changes made in a standardized format for traceability.

    What role do audits play in preventing deviations?

    Regular audits help identify weaknesses in protocols and ensure compliance with established procedures, reducing the risk of deviations.

    Can procedural clarity prevent skipping an IPC?

    Absolutely. Clear and unambiguous written procedures significantly reduce human error and enhance compliance during critical processes.

    What type of records should be kept for inspections?

    Keep all records related to deviations, investigations, CAPA actions, training, and batch documentation to demonstrate compliance.

    How often should I perform re-qualifications?

    Re-qualifications should align with significant process changes, equipment modifications, or when deviations occur that affect process integrity.

    Is there a need for specific IPC training for personnel?

    Yes, specialized IPC training ensures that those involved in the production process understand the critical nature of IPCs and the implications of non-compliance.

    Pharma Tip:  Unplanned hold time extension during inspection preparation – regulatory impact assessment case study